Premium
Classroom Enters the Courtroom: Stereochemistry of S N 1 and S N 2 Reactions in Enantiomer Patent Litigations of the Antidepressant Escitalopram
Author(s) -
Michman Elisheva,
Agranat Israel
Publication year - 2016
Publication title -
chirality
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.43
H-Index - 77
eISSN - 1520-636X
pISSN - 0899-0042
DOI - 10.1002/chir.22501
Subject(s) - escitalopram , chemistry , enantiomer , racemization , oxalate , diol , intramolecular force , stereoselectivity , stereochemistry , organic chemistry , antidepressant , psychology , catalysis , psychiatry , anxiety
The role of elementary stereochemistry is illustrated in the patent litigations of the blockbuster antidepressant drug escitalopram oxalate. An undergraduate student of organic chemistry would recognize the stereochemical courses of the intramolecular S N 2 and S N 1 reactions of the single‐enantiomer ( S )‐diol intermediate in the synthesis of the blockbuster antidepressant drug escitalopram oxalate: retention of configuration of the chiral carbon atom under basic conditions and racemization under acidic conditions, respectively. He/she, in searching for a stereoselective ring‐closure reaction of the enantiomeric diol, will think of an S N 2 reaction in a basic medium. From these points of view, the process claim in the enantiomer patents of escitalopram is obvious/lacks an inventive step. An organic chemistry examination problem based on this scenario is offered. Chirality 28:39–43, 2016 . © 2015 Wiley Periodicals, Inc.